The Effects of Estrogens on Cognition and Alzheimer's Dementia

  • Tony Edwin
  • Uriel Halbreich


Estrous Cycle Congenital Adrenal Hyperplasia Estrogen Replacement Therapy Ovarian Steroid Basal Forebrain Cholinergic Neuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arimatsu Y, Hatamaka H (1986) Estrogen treatment enhances survival of cultured amygdala neurons in a defined medium. Dev Brain Res 26: 151–159CrossRefGoogle Scholar
  2. Armstrong RA (1995) Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer’s disease. Dementia 6: 121–125PubMedGoogle Scholar
  3. Asthana S, Craft S et al. (1999) Cognitive and neuroendocrine response to trans-dermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo controlled, double-blind, pilot study. Psychoneuroendocrinolgy 24: 657–677Google Scholar
  4. Barret-Connor, Kritz-Silverstein D (1993) Estrogen replacement therapy and cognitive function in older women. JAMA 260: 2637–2641Google Scholar
  5. Bartus RT, Dean RL, Beer B, Lippa AD (1981) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 208–217Google Scholar
  6. Birge SJ (1994) The role of estrogen deficiency in the aging of the central nervous system. In: Lobo RA (ed) Treatment of the postmenopausal woman: basic clinical aspects. Raven Press, New York, 153–157Google Scholar
  7. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB (1994) Postmenopausal estrogen replacement therapy and the risk of Alzheimer’s disease: a population-based case-control study. Am J Epidemiol 140: 262–267PubMedGoogle Scholar
  8. Caldwell BM (1954) An evaluation of psychological effects of sex hormone administration in aged women. J Gerontol 9: 168–174PubMedGoogle Scholar
  9. Caldwell BM, Watson RI (1952) An evaluation of psychologic effects of sex hormone administration in aged women. Results of therapy after 6 months. J Gerontol 7: 228–244PubMedGoogle Scholar
  10. Campbell S, Whitehead M (1977) Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1: 31–47Google Scholar
  11. Chakravorthy, Halbreich U (1997) Estrogen and platelet activity in postmenopausal women. Psychopharm Bull 33: 229–233Google Scholar
  12. Chung SK, Pfaff DW, Cohen RS (1988) Estrogen-induced alterations in synaptic morphology in the midbrain central gray. Exp Brain Res 69: 522–530PubMedCrossRefGoogle Scholar
  13. Costa MM, Reus VI (1999) Estrogen replacement therapy and cognitive decline in memory impaired post-menopausal women. Biol Psychiatry 46: 182–188PubMedCrossRefGoogle Scholar
  14. Coyle JT, Price DL, DeLong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219: 1184–1190PubMedGoogle Scholar
  15. Derby CA, Hume AL, McPhillips JB, Rarbour MM, Carleton RA (1995) Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers. Am J Obstet Gynecol 173: 544–550PubMedCrossRefGoogle Scholar
  16. Ditkoff EC, Crary WG, Cristo M, Lobo RA (1991) Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78: 991–995PubMedGoogle Scholar
  17. Faivre-Bauman A, Rosenbaum E, Puymirate J, Grouselle D, Tixier-Vidal A (1981) Differentiation of fetal mouse hypothalamic cells in a serum-free medium. Dev Neurosci 4: 118–129PubMedGoogle Scholar
  18. Fedor-Freybergh P (1977) The Influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 3: 64–69Google Scholar
  19. Fillit H, Weinreb H, Cholst I (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia (Alzheimer’s type). Psychoneuroendocrinology 11: 337–345PubMedCrossRefGoogle Scholar
  20. Hackman R., Galbraith D (1976) Replacement therapy with piperazine oestrone sulfate and its effect on memory. Curr Med Res Opin 4: 303–306PubMedGoogle Scholar
  21. Halbreich U (1995) Estrogen as a potential psychotropic medication. Presented at the 26th Congress of the International Society of Psychoneuroendocrinology, September, Munich, GermanyGoogle Scholar
  22. Halbreich U (1995) Menstrually related disorders: What we do know, what we only believe we know, and what we know that we do not know. Crit Rev Neurobiol 2/3: 163–175Google Scholar
  23. Halbreich U (1997) Role of estrogen in postmenopausal depression. Neurology 48(Suppl 7): 16–20Google Scholar
  24. Halbreich U, Piletz JE, Carson S, Halaris A, and Rojansky N (1993) Increased imidazoline and alpha-2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry 34: 676–686PubMedCrossRefGoogle Scholar
  25. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434–441PubMedGoogle Scholar
  26. Hampson E, Kimura D (1988) Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav Neurosci 102: 456–459PubMedCrossRefGoogle Scholar
  27. Hefti F, Knusel B, Lapchak PA (1993) Protective effects of nerve growth factor and brain derived neurotrophic factor on basal forebrain cholinergic neurons in adult rats with partial fimbrial transections. Progr Brain Res 98: 257–263Google Scholar
  28. Hemminki E, Malin M, Topo P (1993) Selection to postmenopausal therapy by women’s characteristics. J Clin Epiderniol 46: 211–219Google Scholar
  29. Henderson VW (1997) The epidemiology of estrogen replacement therapy and Alzheimers disease. Neurology 48(Suppl 7): 27–35Google Scholar
  30. Henderson YW, Paganini-Hill A, Emmanuel CK, Dunn ME, Buckwalter JG (1994) Estrogen replacement therapy in older women. Comparisons between Alzheimers disease cases and non-demented control subjects. Arch Neurol 51: 896–900PubMedGoogle Scholar
  31. Hogervorst E, Boshuisen M, Riedel W, Willeken C, Jolles J (1999) The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendocrinology 24: 43–68PubMedCrossRefGoogle Scholar
  32. Honjo H, Ogino Y, Naitoh K (1989) In vivo effects by estrone sulfate on the central nervous system: Senile dementia (Alzheimer’s type). J Steroid Biochem Mol Biol 34: 521–525Google Scholar
  33. Jarvik LF (1975) Human intelligence: sex differences. Acta Genet Med Gemellol (Rome) 24: 189–211PubMedGoogle Scholar
  34. Jorm AF, Korten AE, Henderson AS (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76: 465–479PubMedGoogle Scholar
  35. Kahn L, Halbreich U (1999) Menopause and psychopharmacology: signs, symptoms, and treatment. In: Crosignani PG, Kenemans K, Wenger NK, Jackson AS (eds) Women’s Health and Menopause: Risk Reduction Strategies — Improved Quality of Health. Kluwer Academic Publishers, Boston, 131–136Google Scholar
  36. Kampen D, Sherwin B (1994) Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83: 979–83PubMedCrossRefGoogle Scholar
  37. Kantor HI, Michael CM, Shore H (1973) Estrogen for older women. Am J Obstet Gynaecol 116: 115–118Google Scholar
  38. Kawata M (1995) Roles of steroid hormones and their receptors in structural organization in the central nervous system. Neurosci Res 24: 1–46PubMedCrossRefGoogle Scholar
  39. Kendall DA, Stancel GM, Enna SJ (1981) Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science 211: 1183–1185PubMedGoogle Scholar
  40. Lerner A, Cole R, Debanne S (1995) Immunological and endocrine conditions in an Alzheimer’s disease case-control study (abstract). Neuroepidemiology 14: 307Google Scholar
  41. McEwen BS, Alves SE, Bulloch K, Weiland NG (1997) Ovarian steroids and the brain: implications for cognition and aging. Neurology 48(Suppl 7): S8–S15PubMedGoogle Scholar
  42. McEwen BS, Woolley CS (1994) Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 29: 431–436PubMedCrossRefGoogle Scholar
  43. Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801–1811PubMedCrossRefGoogle Scholar
  44. Morrison A, Resnik S, Corrada M, Zonderman A, Kawas C (1996) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease in the Baltimore longitudinal study of aging (abstract). Neurology 46(Suppl 2): 435–436Google Scholar
  45. Mortel KF, Meyer JS (1995) Lack of postmenopausal estrogen replacement therapy and risk of dementia. J Neuropsychiatr Clin Neurosci 7: 334–337Google Scholar
  46. Nass R, Raker S (1991) Androgen effects on cognition: congenital adrenal hyperplasia. Psychoendocrinology 16: 189–201Google Scholar
  47. Nee LE, Eldrige R, Sunderland T, Thomas CB, Katz D, Thompson KE, Weingartner H, Weiss H, Julian C, Cohen R (1987) Dementia of the Alzheimer type: clinical and family study of 22 twin pairs. Neurology 37: 359–363PubMedGoogle Scholar
  48. Ohkura T, Teshima Y, Isse K, et al (1994) Estrogen increases cerebral and cerebellar blood flows in postmenopausal. Menopause 2: 13–18Google Scholar
  49. Okhura T, Isse K, Akazawa K (1995) Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer’s type: 7 case reports. Dementia 6: 99–107Google Scholar
  50. Paganini-Hill A, Henderson VW (1994) Estrogen deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 140: 256–261PubMedGoogle Scholar
  51. Paganini-Hill A, Henderson YW (1996) Estrogen replacement therapy and risk of Alzheimer’s disease. Arch Intern Med 156: 2213–2217PubMedCrossRefGoogle Scholar
  52. Pericak-Vance MA, Haines JL (1995) Genetic susceptibility to Alzheimer’s disease. Trends Genet 11: 504–508PubMedCrossRefGoogle Scholar
  53. Perlman S (1973) Cognitive abilities of children with hormone abnormalities: screening by psychoeducational tests. J Learn Disabil 6: 24–34CrossRefGoogle Scholar
  54. Phillips SM, Sherwin ER (1992) Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17: 485–495PubMedGoogle Scholar
  55. Polderman KR, Sthouwer CD, van Kamp GJ, Schalkwijk CG, Gooren LJ (1993) Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118: 429–432PubMedGoogle Scholar
  56. Rarrett-Connor, E and Goodman-Gruen (1999) Cognitive function and endogenous sex hormones in older women. J Am Geriatr Soc 11: 1289–1293Google Scholar
  57. Regland B, Gottfries CG (1992) The role of amyloid beta-protein in Alzheimer’s disease. Lancet 340: 467–469PubMedCrossRefGoogle Scholar
  58. Resnik S, Berenbaum S, Gottesman T, Bouchard T (1986) Early hormonal influences on cognitive functioning in congenital adrenal hypreplasia. Dev Psychol 22: 191–198Google Scholar
  59. Rirge SJ (1997) The role of estrogen in the treatment of Alzheimer’s disease. Neurology 48(Suppl 7): 36–41Google Scholar
  60. Rosencrans JA (1970) Differences in brain area 5-hydroxytryptamine turnover and rearing behavior in rats and mice of both sexes. Eur J Pharmacol 9: 379–382Google Scholar
  61. Sar M, Stumpf WE (1981) Central noradrenergic neurones concentrate 3H-oestradiol. Nature 289: 500–502PubMedCrossRefGoogle Scholar
  62. Schneider LS, Farlow MR, Henderson VW, Pogoda JM (1996) Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer’s disease. Neurology 46: 1580–1584PubMedGoogle Scholar
  63. Shaywitz SE, Shaywitz BA, Pugh KR et al. (1999) Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 281: 1197–1202PubMedCrossRefGoogle Scholar
  64. Sherwin BB (1997) Estrogen effects on cognition in menopausal women. Neurology 48(Suppl 7): 21–26Google Scholar
  65. Sherwin BB, Phillips S (1990) Estrogen and cognitive functioning in surgically menopausal women. Ann NY Acad Sci 592: 474–475Google Scholar
  66. Sherwin BR, Tulandi T (1996) "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81: 2545–2549PubMedCrossRefGoogle Scholar
  67. Sherwin ER (1994) Estrogenic effects on memory in women. Ann NY Acad Sci 743: 213–231PubMedGoogle Scholar
  68. Shugrue PJ, Dorsa DM (1993) Estrogen modulates the growth-associated protein GAP-43 (neuromodulin) mRNA in the rat preoptic area and basal hypothalamus. Neuroendocrinology 57: 439–447Google Scholar
  69. Singh M, Meyer EM, Millard WJ, Sirnpkins JW (1994) Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644: 305–312PubMedCrossRefGoogle Scholar
  70. Small GW, Leuchter AF, Mandelkern MA, La Rue A, Okonek A, Lufkin RB, Jarvik LF, Matsuyama SS, Bondareff W (1993) Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type. Arch of Neurol 50: 209–219Google Scholar
  71. Sorabji F, Miranda RC, Toran-Allerand CD (1994) Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 14: 459–471Google Scholar
  72. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayenx R (1996) Effect of estrogen during menopause on risk and age at onset of Alzheime’s disease. Lancet 348: 429–432PubMedCrossRefGoogle Scholar
  73. Terasawa E, Timiras P (1968) Electrical activity during the estrous cycle of the rat: cyclic changes in limbic structures. Endocrinology 83: 207–216PubMedCrossRefGoogle Scholar
  74. Toran-Allerand CD (1984) On the genesis of sexual differentiation of the central nervous system: morphogenic consequences of steroidal exposure and possible role of a fetoprotein. Progr Brain Res 61: 63–98Google Scholar
  75. Toran-Allerand CD (1993) Orgnotypic culture of the developing cerebral cortex and hypothalamus: relevance to sexual differentiation. Psychoneuroendocrinology 57: 439–447Google Scholar
  76. Toran-Allerand CD, Miranda RC, Bentharn WD, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ (1992) Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 89: 4668–4672PubMedGoogle Scholar
  77. Van Buren G, Yang D, Clark KE (1992) Estrogen-induced uterine vasodilation isantogonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167: 828–833PubMedGoogle Scholar
  78. Van Duijn CM, Hofman A (1992) Risk factors for Alzheimer’s disease: the EURODEM collaborative re-analysis of case-control studies. Neuroepidemiology 11(Suppl 1): 106–113PubMedGoogle Scholar
  79. Warren SG, Humphreys AG, Juraska JM, Greenough WT (1995) LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res 703: 26–30PubMedCrossRefGoogle Scholar
  80. Wong M, Moss RL (1992) Long-term and short-term electrophysiological effects of estrogen on the synaptic properties hippocampal CA1 neurons. J Neurosci 12: 3217–3225PubMedGoogle Scholar
  81. Woolley CS, McEwen BS (1993) Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 57: 935–939Google Scholar
  82. Wu X, Glinn MA, Ostrowski NL, Su Y, Ni B, Cole HW, Bryant HN, Paul SM (1999) Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyl-transferase activity in ovarectomized rats. Brain Res 847: 98–104PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • Tony Edwin
  • Uriel Halbreich

There are no affiliations available

Personalised recommendations